LAVAL, QC, Jan. 3 /PRNewswire-FirstCall/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Thursday, January 10, 2008, Dr. Francesco Bellini, Chairman, President and CEO, will present Neurochem's overall strategy at the 26th Annual JPMorgan Healthcare Conference to be held at the Westin St. Francis Hotel, in San Francisco (CA). The presentation will take place at 2:00 P.M. PST, in the Elizabethan A & B room.
Neurochem Inc. is a global health company focused on the research, development and commercialization of products to provide innovative health solutions to patients suffering from serious diseases.
To Contact Neurochem
For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1-877-680-4500 or visit our Web Site at http://www.neurochem.com.
Certain statements contained in this news release, other than
statements of fact that are independently verifiable at the date hereof,
may constitute forward-looking statements. Such statements, based as they
are on the current expectations of management, inherently involve numerous
risks and uncertainties, known and unknown, many of which are beyond
Neurochem Inc.'s control. Such risks include but are not limited to: the
impact of general economic conditions, general conditions in the
pharmaceutical and/or nutraceutical industry, changes in the regulatory
environment in the jurisdictions in which the Neurochem group does
business, stock market volatility, fluctuations in costs, and changes to
the competitive environment due to consolidation, that actual results may
vary once the final and quality-controlled verification of data and
analyses has been completed, as well as other risks disclosed in public
filings of Neurochem Inc. Consequently, actual future results may differ
materially from the anticipated results expressed in the forward-looking
statements. The reader should not place undue reliance, if any, on any
forward-looking statements included in this news release. These statements
speak only as of the date made and Neurochem Inc. is under no obligation
and disavows any intention to update or revise such statements as a result
of any event, circumstances or otherwise. Please see the Annual Information
Form of Neurochem Inc. for further risk factors that might affect the
Neurochem group and its business.
For further information, please contact:
Lise Hebert, PhD Tel: (450) 680-4570
Vice President, Corporate Communications firstname.lastname@example.org
|SOURCE NEUROCHEM INC.|
Copyright©2008 PR Newswire.
All rights reserved